Category: BioNTech
-
New COVID-19 vaccine patent suit: BioNTech v. Moderna
BioNTech has sued Moderna in the United States District Court for the District of Delaware, alleging that the defendant’s most profitable vaccine mNexspike infringes on its key RNA technology.
-
Bayer adds to COVID patent wars: sues Pfizer/BioNTech, Moderna, J&J over mRNA technologyÂ
Bayer’s Monsanto has sued Pfizer/BioNTech, Moderna, and Johnson & Johnson over the alleged infringement of a patent related to gene sequencing technology through their COVID-19 vaccinations.
-
Pfizer, BioNTech hit back against GSK mRNA suits in UPC, Ireland: file UK revocation actionÂ
The move does not come as a major surprise, given the pharma companies’ previous success against GlaxoSmithKline in the UK.
-
BREAKING: GSK cashes in on license deal as CureVac settles U.S. patent dispute with acquirer BioNTech and Pfizer for $790M+
Pfizer and BioNTech have settled their three-year COVID vaccine-related patent infringement dispute with CureVac in the U.S., granting the latter and its licensing partner GSK $370 million each.